In MM, tumor plasma cells with a mature phenotype gain a certain degree of phenotypic plasticity by expressing specific stem cell progenitor markers, such as SOX2, MAGE, CD117 (KIT), and Nestin [96,97,98,99]. This evidence concerns the gene KIT and neoplasm.